Journal of Equine Veterinary Science
Volume 26, Issue 11 , Pages 517-528, November 2006

Estradiol interactions with dopamine antagonists in mares: Prolactin secretion and reproductive traits

  • K.K. Kelley, MS

      Affiliations

    • Department of Animal Sciences, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Baton Rouge, LA
  • ,
  • D.L. Thompson Jr, PhD

      Affiliations

    • Department of Animal Sciences, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Baton Rouge, LA
    • Corresponding Author InformationReprint requests: D.L. Thompson, Jr., Department of Animal Sciences, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, S. Campus Drive, Francioni Hall, Baton Rouge, LA 70803
  • ,
  • W.A. Storer, MS

      Affiliations

    • Department of Animal Sciences, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Baton Rouge, LA
  • ,
  • P.B. Mitcham, BS

      Affiliations

    • Department of Animal Sciences, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Baton Rouge, LA
  • ,
  • R.M. Gilley, BS

      Affiliations

    • BioRelease Technologies, Birmingham, AL
  • ,
  • P.J. Burns, PhD

      Affiliations

    • BioRelease Technologies, Birmingham, AL
    • Burns BioSolutions, Lexington, KY

Abstract 

Two experiments studied the effects of pretreatment with estradiol benzoate before treatment with a dopamine antagonist on prolactin secretion and reproductive traits in mares during (1) the seasonal anovulatory period and (2) the normal breeding season. Experiment 1 was performed in winter with 17 mares selected for low follicular activity. Nine mares received estradiol benzoate injections every other day for a total of 10 injections; 8 mares received similar injections of vehicle. Ten days after onset of injections, all mares were placed on daily injections of sulpiride (250 mg) for 35 days or until ovulation. Plasma prolactin concentrations were higher (P < .001) in mares receiving estradiol than in controls for all assessments from days 12 through 36. Plasma luteinizing hormone (LH) concentrations were also increased (P < .05) by estradiol treatment from days 14 to 23. Mean day of first ovulation was 73.6 for control mares and 29.0 for estradiol-treated mares (P = .016). Estradiol treatment greatly enhanced prolactin secretion in response to sulpiride and increased LH secretion in seasonally anovulatory mares, which together hastened the date of first ovulation by an average of 45 days. Experiment 2 was designed to assess the efficacy of a long-acting, single-injection microparticle preparation of another dopamine antagonist, domperidone, for increasing prolactin secretion in cyclic mares in the summer. The experimental design and procedures used in experiment 1 were repeated, except that a single 3-g domperidone-microparticle injection was administered on day 11 rather than 45 days of sulpiride injections. Day 0 was the first day of estrus for each mare. Prolactin concentrations were higher (P < .05) in mares receiving estradiol than in control mares from days 12 through 25 and after a thyrotropin-releasing hormone injection on d 21. Estrous cycle traits (time to ovulation and time of luteal regression) were not affected (P > .1) by treatment. Estradiol enhanced the prolactin response to a single injection of 3 g domperidone in cyclic mares in the summer in a manner similar to the estradiol enhancement of prolactin secretion in response to daily sulpiride injections in anovulatory mares in winter. Thus, the single injection of domperidone could possibly replace the daily sulpiride injections used in experiment 1 to induce ovulation in seasonally anovulatory mares; this needs to be tested in future experiments.

Keywords:  Mares , Domperidone , Prolactin , Seasonal reproduction , Sulpiride

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 15.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 RefereedApproved for publication by the Director of the Louisiana Agric. Exp. Stn. as manuscript No. 06 18 0228. We thank A.F. Parlow and the Natl. Inst. of Diabetes and Digestive and Kidney Diseases, National Hormone and Pituitary Program, Harbor University of California Los Angeles Medical Center, Torrance, CA, for reagents.

PII: S0737-0806(06)00499-0

doi:10.1016/j.jevs.2006.09.008

Journal of Equine Veterinary Science
Volume 26, Issue 11 , Pages 517-528, November 2006